Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
GC Genome Announces Publication Demonstrating Feasibility of Liquid Biopsy Technology to Predict Radiation Therapy Response in Solid Tumors 2023-04-10 11:39
China's First Nectin-4 Targeted ADC 9MW2821 Clinical Progress Released 2023-04-07 16:34
Nuance Pharma Announces Dosing of First Patient in ENHANCE - China Phase III Trial for Chronic Obstructive Pulmonary Disease ("COPD") 2023-04-07 10:00
AnPac Bio-Medical Science Announces Closing of $3.0 Million Registered Direct Offering 2023-04-07 07:15
GC Cell Obtains Anti-bribery Management System Certification 2023-04-06 18:03
Nona Biosciences Enters into Collaboration Agreement with ExeVir Bio 2023-04-06 10:20
Biosion Initiates Phase II Clinical Trial of BSI-045B in Atopic Dermatitis 2023-04-04 20:50
Lynk Pharmaceuticals Announces Positive Results for LNK01003 in Phase I Trial in Healthy Subjects 2023-04-04 20:00
iNtRON confirms cancer-controlling effect of PHAGERIA® drug candidate in the organoid model. 2023-04-04 10:33
AnPac Bio-Medical Science Enters into Asset Purchase Agreement with Easy Hundred Inc. 2023-04-03 21:00
GC Cell and New Management Embarking on a New Chapter 2023-04-03 16:47
Harbour BioMed Reports Full Year 2022 Financial Results 2023-04-03 15:10
The World's Second Approved Biosimilars of Denosumab (MAILISHU) 2023-04-03 13:44
CBC Group Appoints Healthcare Veteran Abbas Hussain as Operating Partner 2023-04-01 10:00
Hugel Appointed Suk-yong Cha as Executive Chairman and Chairman of the Board Accelerating Transformation into a Global Top-tier Company 2023-03-31 20:00
I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Year Ended December 31, 2022 2023-03-31 18:30
Genscript Biotech Reports 2022 Annual Results* 2023-03-31 08:40
Kintor Pharma Announces 2022 Annual Results and Recent Business Progress 2023-03-31 00:33
Actinogen presents positive Phase 2a Xanamem data in at ADPD™ Alzheimer's and Parkinson's diseases conference 2023-03-30 21:00
ACROBiosystems' new strategic focus - streamlining the transition from preclinical development to commercialization 2023-03-30 18:54
1 56 57 58 59 60 222